Global liver disease burdens and research trends: analysis from a Chinese perspective

J Xiao, F Wang, NK Wong, J He, R Zhang, R Sun… - Journal of …, 2019 - Elsevier
Liver diseases affect millions of people worldwide. In most developed countries, the
incidence of viral hepatitis is waning as a result of modern advances in disease prevention …

Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence

JL Raoul, A Forner, L Bolondi, TT Cheung… - Cancer treatment …, 2019 - Elsevier
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, representing the
sixth leading cause of cancer and the third leading cause of cancer-related mortality. Patient …

[HTML][HTML] Global incidence and mortality of breast cancer: a trend analysis

J Huang, PSF Chan, V Lok, X Chen, H Ding… - Aging (Albany …, 2021 - ncbi.nlm.nih.gov
This study aimed to evaluate the global incidence and mortality trends of breast cancer
among females by region and age in the past decade. We retrieved country-specific …

Incidence and mortality of lung cancer: global trends and association with socioeconomic status

MCS Wong, XQ Lao, KF Ho, WB Goggins, SLA Tse - Scientific reports, 2017 - nature.com
We examined the correlation between lung cancer incidence/mortality and country-specific
socioeconomic development, and evaluated its most recent global trends. We retrieved its …

The changing epidemiology of liver diseases in the Asia–Pacific region

MCS Wong, JLW Huang, J George, J Huang… - Nature reviews …, 2019 - nature.com
This Review presents current epidemiological trends of the most common liver diseases in
Asia–Pacific countries. Hepatitis B virus (HBV) remains the primary cause of cirrhosis; …

Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model

T Kimura, YU Kato, Y Ozawa, K Kodama, J Ito… - Cancer …, 2018 - Wiley Online Library
Angiogenesis inhibitors such as lenvatinib and sorafenib, and an immune checkpoint
inhibitor (ICI), nivolumab, are used for anticancer therapies against advanced hepatocellular …

The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection

MCS Wong, FDH Fung, C Leung, WWL Cheung… - Scientific reports, 2018 - nature.com
We tested the hypotheses that the global incidence of bladder cancer was increasing but its
mortality was reducing and its incidence was positively correlated with country-specific …

The role of matrix metalloproteinases in the epithelial‐mesenchymal transition of hepatocellular carcinoma

C Scheau, IA Badarau, R Costache… - Analytical cellular …, 2019 - Wiley Online Library
The epithelial‐mesenchymal transition (EMT) is a transformation process mandatory for the
local and distant progression of many malignant tumors, including hepatocellular carcinoma …

[HTML][HTML] Obesity and the risk of primary liver cancer: A systematic review and meta-analysis

W Sohn, HW Lee, S Lee, JH Lim, MW Lee… - Clinical and …, 2021 - ncbi.nlm.nih.gov
Methods This study was conducted using a systematic literature search of MEDLINE,
EMBASE, and the Cochrane Library until November 2018 using the primary keywords …

Fructose and the Liver

P Muriel, P López-Sánchez… - International journal of …, 2021 - mdpi.com
Chronic diseases represent a major challenge in world health. Metabolic syndrome is a
constellation of disturbances affecting several organs, and it has been proposed to be a liver …